All material published in the newsletter is checked for accuracy by leading uveitis specialists. The patient's view section is not checked in this way and is a chance for people to share their views and experiences.
IntroductionThere has been a bit of a gap since the last newsletter due to a variety of other commitments I’m afraid, but here we are again. The use of eye drops forms the main theme of this newsletter. This is a subject that is easy to overlook, as it seems a rather simple topic. However it forms the mainstay of treatment of the condition for most people, and I’m sure it is worth looking into the different types of drops used and how best to use them. I
would imagine that there are many things taken for granted about taking eye
drops so I hope even experienced users will benefit from going over their use. The
first of these meetings has now been set for this autumn, at Moorfields Eye
Hospital in London. I hope to see as many people there as possible.
See below for more details. Phil Hibbert News Public meeting Later this year, on Saturday, November 8th a public meeting will be held at Moorfields Eye Hospital in London. This will be the first public meeting of the group and hopefully will become the first of regular annual meetings. It is also hoped that similar meetings could be arranged in future in different regions, in Scotland and the South West for example. Professor Susan Lightman, a leading specialist in uveitis, who is based at Moorfields, will speak at the meeting. It is hoped there will be an opportunity to meet with other people such as family support staff at Moorfields. The meeting will focus entirely on the needs of patients and cover up to date treatment and research news and practical advice. There are smaller address exchanges for families with children with uveitis and also nursing staff. These seem to working well and anyone who wishes to be added or wants to find out about these, then please contact us. Eye Drops: Their use in Uveitis Patient Eye drops are used to deliver
a variety of medications to our eyes. They may have different purposes which
include;
· Treatment, e.g. antibiotics,
steroid drops · Aids to diagnosis e.g. drops
to aid an eye examination, or the drops used in measurement of eye pressure. ·
Local anaesthetics to aid
examination or to enable the Ophthalmologist to perform simple surgical
procedures. Eye drops
are just one means of administering drugs to treat uveitis and its possible
complications. The other main methods, including injections and systemic
treatments (tablets) are not covered in this article. There is not
a ‘best’ or ‘standard’ way to treat uveitis.
The type of drug and whether it is to be administered by eye drop or
tablet or whatever will depend on the type, the part of the eye affected and the
severity of the uveitis. As we know
uveitis can be an extremely variable condition. Starting with
the main use of eye drops in uveitis patients, the 1.
Treatment of inflammation, that is, treatment of the uveitis. 2.
Treatment of complications or side effects that arise in cases of
uveitis. The
differences between 1.and 2. are important to understand because, as a patient,
it is always useful to know what your current treatment is aiming to achieve. Is
your uveitis active, (is there inflammation present?).
If it is active, is this what your drops are for?
There may be
other things going on with or without inflammation, which need different types
of treatment. An example would be a rise in pressure inside the eye, which can
be treated by a specific type of drop. Most cases of
anterior uveitis are treated with eye drops alone. There are
different steroid drops available and the Ophthalmologist selects the best drop
for each individual’s situation. There is a
large range of steroid eye drops that the Ophthalmologist can choose from. The main
choice to be made is the strength of the drop to be used. This will depend on
the severity of the inflammation and other factors, possibly, such as the
perceived threat to vision or whether only one or two eyes are involved. The general
principle of treatment nowadays is to treat any inflammation aggressively, with
a high initial dose, tapering down as soon as possible to no drops or a minimal
dose. This method
will hopefully bring inflammation under control as quickly as possible, whilst
still delivering the least amount of steroid over a long period of time. It is well
known that the use of steroid drops can increase the chance of developing a
cataract or having raised eye pressure. The aim of treatment then becomes a
balancing act between the ‘zero tolerance’ to inflammation and aggressive
treatment on one hand and a desire to minimise the side effects on the other. Examples of
some of the main steroid drops are given below. They are listed with the
‘strongest’ drops at the top. Dexamethasone
0.1% (maxidex) Pred Forte®
(Allergan)
Eye drops, prednisolone acetate
1%. Predsol®
(Celltech)
Drops (for ear or eye),
prednisolone sodium phosphate 0.5% Vexol® (Alcon)
Eye drops, rimexolone 1%,
These drugs
can be prescribed after surgery to reduce inflammation, but are often not strong
enough to treat uveitis alone. They also help maintain dilation of pupil. Examples are: Ketorolac
(Acular) Fluribprofen
(Ocufen)
Diclofenac (Volterol
Ophtha)) c)
Mydriatics / Cycloplegics These
are what are generally known as ‘the dilating drops’. In
anterior uveitis, the iris becomes inflamed. To relieve pain and, very
importantly, to prevent the lens sticking to the eye (posterior synechiae), then
this group of eye drops are used. They work by paralysing the iris (a muscle), and dilating the
pupil. Whilst their use is
important to avoid complications, their main disadvantage is that they will blur
the vision. Because of this, the
type of mydriatic used is chosen carefully, to produce the required effect
whilst causing as little inconvenience to the patient. Examples of
mydriatics are: atropine:
This is fairly long acting (1% may last around 2 weeks), and is required with
severe inflammation and where there is a high risk of synechiae formation. cyclopentolate:
(often known as mydrilate) This
is used in less severe cases and is still fairly long acting. homatropine:
similar length of action as cyclopentolate tropicamide:
(sometimes known as mydracyl). This
is a short acting drug and may be used as a night-time drop, when only
intermittent mydriasis is needed. phenylephrine:
this is often used in combination with other mydriatics, more often for dilation
as part of the examination performed by your Doctor. These
‘dilating drops’ are used to treat the symptoms of uveitis and also to
prevent the formation of posterior synechiae. In this way, they almost fall into
the next group. 2.
Treatment of complications or side effects that arise in cases of uveitis Sometimes,
complications will arise in cases of uveitis.
If so, they can usually be simply dealt with and managed.
Occasionally the complication can ‘take over’ as the main problem
whilst the uveitis may be under reasonable control.
The complication may be as a result of the damage done by the
inflammation in the first place, but it can also be an unfortunate but
acceptable side effect of the steroid treatment. The main
example of eye drops used in this way is the drugs used to treat raised eye
pressure: ·
Beta-blockers eg betaxolol,
carteolol, levobunolol, and timolol. As
some systemic absorption may occur, then these types of drops may be avoided in
patients with certain heart problems and asthmatics. · Carbonic
anhydrase inhibitors. If
beta-blockers are not suitable, e.g. for asthmatics, or if the rise in eye
pressure is not easily controllable, this group of drugs is used.
Acetazolamide is given by mouth or by intravenous injection. This drug is
given if drops alone cannot control the pressure. It is not ideal for long-term
use and is associated with quite a few systemic side effects.
Dorzolamide is basically the same drug as acetazolamide but in drop form.
This is mainly used in patients who cannot take beta-blockers but is sometimes
used in combination with beta-blockers. · a-
2 antagonists (alpha 2 antagonists). Examples
are apraclonidine and brimonidine. These drugs are generally not used long term but may be used,
for short periods postoperatively. · Prostaglandin Analogues (Brimatoprost,
Latanoprost, Travoprost). These
agents need only be taken once a day, often at night. Their role in treatment of
glaucoma as a complication of uveitis is uncertain, but is becoming increasingly
prescribed. Other uses of eye drops
The eye drops we come across as uveitis patients may not all be concerned with the direct treatment of the condition. Eye drops may
be used in the clinics for a variety of reasons: local
anaesthetics, These are used to
help examine eyes, and in combination with other preparations can be used to
measure pressure in the eye. mydriatics.
This group already covered, are commonly used to dilate the patient’s
pupils to enable the Ophthalmologist
to see into the eye more easily. What happens to eye drops
placed into the eye? Eye drops
penetrate the eye directly through the cornea into the anterior chamber. A
single drop is all that the ‘pocket’ formed by the lower lid can hold. Any
more will flow overflow or pass down the tear duct into the nose. (Hence, when
taking drops, just a single one should be placed). The eye drop may enter the
rest of the body by getting into the systemic blood circulation. It does this by
passing through the nasal mucosa after going down the tear duct or by entering
the small blood vessels in the conjunctiva. Whether this
happens to any significant degree is not absolutely sure but it does seem
possible. The significance of any
systemic side effects would vary with the type of drop and its overall dosage,
and possibly with other existing medical conditions or with pregnancy and
breastfeeding. It is possible to reduce any systemic absorption by
‘occluding’ the tear duct. This involves pressing down on the inside corner
of the closed eye after placing the drop for about a minute. A nurse at the
clinic would be able to show you this if you weren’t sure. There should
be very little to worry about with the amount of a drug that can be absorbed in
this way, but if you have any concerns then it may be a good idea to have a word
with your doctor. I know many of you of you reading this will have placed more eye drops than I have had hot dinners, but it is often the simplest things that get taken for granted or forgotten, and so it was thought worthwhile at least to offer some ‘revision’. If you have just started using eye drops then hopefully this will make sense of them and prevent any bad habits appearing. Firstly it is a good idea to know what type of eye drops you have, what they are achieving, and what potential side effects to watch out for. Taking Eye Drops There will probably be a bit of variation in what instructions are given in different clinics but there are basically 2 different methods, which are covered below: To avoid confusion set out the eye drop bottles in order, separating those for the right and left eyes, if both are needed. Have ‘drops to go in’ and a ‘drops taken’ places to avoid repeating any: I apologise if this sounds simple but, if like me, you are not a naturally organised person then it is worth getting a method you can stick to. Then:
1. Wash hands and remove the lid of the 1st set of drops. 2. Tilt your head up and gently pull down the lower lid with one hand. Then look up. 3. Now apply the eye drop by either A or B below:
4. Now gently squeeze a single drop into the pocket formed by pulling the lower lid down. 5. Close the eye and without rubbing the eye, gently dab any excess drop away with clean cotton wool or tissue. 6. Replace the lid onto the bottle straight away and wash the hands again. General Pointers · If you have different types of drops to put into the same eye, then try and leave 5 mins. between each. If one is an ointment then put the drops in first. ·
Storage of drops Once started, a
bottle of eye drops must be discarded after 4 weeks.
Most drops should be stored at room temperature. Only certain drops must
be stored in the fridge. This will normally be clear on the bottle. (Examples
are cyclopentolate). ·
Some drops may make the vision blurred for
variable amounts of time. If this is the case then plan when they are taken so
as to avoid driving or work. ·
You may be asked to stop the eye drops
escaping from the eye by ‘blocking’ the tear duct so that the drops don’t
run away through it. This can be done by pressing on the inside of the closed
eye with the index finger for a couple of minutes. Do not worry about this, as
this is only necessary with some kinds of drops. Follow the doctor or nurse’s
instructions. ·
If you notice any marked stinging or
irritation after placing eye drops then report this to your doctor. ·
Some people with anterior uveitis know the
signs of a flare up starting quite well. If this is the case it may well be
worth asking your eye clinic for a supply of drops if you are going away on
holiday, for example. (Making sure to check about shelf life of unopened drops
etc.). A Patient’s
view
Two uveitis sufferers have sent in accounts
of their experiences of uveitis.
Carol
Slater, from North Wales gives a personal account of her uveitis. Before I contacted the Uveitis Information Group I
felt quite isolated, having only ever known one lady who had experienced iritis
once in her life and could not really help me. I was first diagnosed as suffering from iritis in my
right eye, November 1998. My husband took me to the local Eye Casualty
Department, although my G.P. was trying to treat the condition at the time. It
was at this point I asked for all the necessary blood tests, but nothing else
showed up, which I was pleased about. I would say at this point, no one tells you the
seriousness of Iritis. I found it difficult to do my work; I had not used the
eye drops at the correct intervals, because I had not learnt to do this for
myself and generally made things worse. Unfortunately my employer was not
supportive towards me. I realised even if I did not get paid for being off sick,
I had to stay away from my part time work and get my eye right again. The only
way to do this was to use all the drops the hospital had given me correctly
(Predforte and Cyclopentolate). Towards the end of my nine weeks away from work
I found out that the recent Contract of Employment I had signed, which stated I
did not get paid if I went off sick, did not apply, and that I was entitled to
sickness benefit from my employer. My next reoccurrence of iritis was December 1999. By
this time I had learned my lesson, not to work whilst being treated and had of
course got the knack of putting my own eye drops in (easy when you know how! )
This time I was off work five weeks. Things went quiet again, thankfully because it was my
only daughter’s wedding in March 2000. Then once again the iritis flared up again in April
2000. I was back on the Predforte and Cyclopentolate. Then I was able to stop
the Predforte for just twelve days from 16 June 2000 to 28June 2000. After that
even up to this present day I have been on various eye drops mostly Predforte.
In the year 2000 I had five attacks of iritis and in the end I had to stop
working altogether, because not being able to see properly I was beginning to
make mistakes and found the pressure of the job increasingly stressful. Even
whilst being off work I have had one more attack in March 2001. I can see that the hospital has had quite a job to
get control of my condition. My consultant has said that no one is to tell me to
stop using the eye drops (as the nurse practitioner at the hospital did at one
point) I am now on non-steroid anti-inflammatory drops twice a day. I feel at
present as though I am hanging on by my fingernails! I am still away from work, believing that if I return
I would simply go back to square one and I am not prepared to do that, my eye
sight is more precious to me than work. In February 2002 my Incapacity Benefit was stopped
and I am currently appealing against that decision. With the help of all the
information of the Uveitis Information Group I believe I am in a better position
to prepare my case for the appeal, knowing so very much more about Uveitis. I hope that the experience I have been through will
help some one else. We are born with two eyes and I will continue to fight to
save the sight in mine. At the age of 58 I feel “ the system” we have
contributed to in our working life has let me down badly. Next,
Barbara Ransom gives an account of her experience with uveitis. I
was involved in a car accident in 1999. I was hit from behind very hard and
suffered a painful whiplash injury. A
couple of days later I noticed my left eye was bloodshot and red and for weeks
after, and for weeks after the accident, it would come and go, but gradually got
worse. I didn’t think anything of it and didn’t link it to the accident. It
got really bad over a couple of days so I thought I had conjunctivitis. My
doctor briefly examined me and gave me some ointment. It didn’t go away and he
was concerned and got me an appointment at the eye clinic that day.
After a few appointments there, they diagnosed iritis. It has been a
roller coaster of emotions for me. I
have been told that I have a small tear in the back of my eye that will repair
itself and the iritis should subside. One Consultant was in no doubt that the
accident caused my iritis (he called it an eye trauma). I’ve seen many different Consultants and the feedback I am getting is that shock or stress from my accident could well have brought it on. I’ve also been left with an injured left shoulder, which is ongoing problem. It’s like the accident shook my whole system up and certainly hasn’t felt the same since. Both my eyes were healthy before the accident and I feel 100% that my iritis was caused by the accident. I have now a battle ahead to prove it. It’s hard for some people to understand why I need to do this for myself, but I feel angry this has happened to me. |
|
Uveitis Information Group is a charity registered in Scotland, no. SCO28439 |